Latest Amgen News & Updates
See the latest news and media coverage for Amgen. We track all announcements, press releases, and industry mentions in real time, all in one place.
Multinational biopharmaceutical company
amgen.com- Headquarters
- Thousand Oaks, United States
- Founded year
- 1980
- Company type
- Public company
- Number of employees
- 40,000+
Last updated
Latest news about Amgen
In short: Amgen reported strong first-quarter 2026 financial growth and significant pipeline developments despite regulatory scrutiny and patent challenges.
Company announcements
-
Amgen invests $125M in next-generation labs
The South San Francisco facility integrates chemistry, biology, and data science using DMTA cycle to accelerate small molecule drug discovery.
-
Amgen announces $300 million U.S. manufacturing investment
This adds to nearly $2 billion invested over the last year, expanding Puerto Rico facility for biologics production and supply chain resilience. It supports jobs and next-generation technologies.
-
Amgen's Shannon Turley inducted into National Academy of Sciences
She receives top U.S. honor for immunology and oncology research impacting cancer immunotherapies. As VP of Research, she advances drug discovery.
-
Amgen shares 2026 Q1 earnings highlights
16 brands achieve double-digit growth. CEO confident in long-term growth amid patent expirations and competition.
Media coverage
-
5 must-read analyst questions from Amgen's Q1 earnings call
Amgen's first quarter results reflected the company's ability to outpace the impact of ongoing patent expirations and increased competition. Management credited strong sales growth in...
-
Amgen’s US$300m Biologics Push And What It Means For AMGN Stock
Amgen announced a $300 million expansion of its U.S. biologics manufacturing network. The plan includes a significant new ...
-
Amgen's Retreat: Denmark, Repatha, And The Collision Course Of US MFN Pricing Policy
Repatha's withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing proposals in the US. When...
-
What’s at stake in Amgen’s showdown with the FDA?
The agency accused Amgen of manipulating data for its fast-growing drug Tavneos and wants it pulled from the market, but the large pharma is digging...
Track Amgen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Amgen competitors & trending companies
Browse news for competitors to Amgen and other trending companies.
AstraZeneca
Lilly
Biogen
Novartis
MSD
BMS
Sanofi
GSK
AbbVie
Gilead
Roche
Merck
Pfizer
Regeneron
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies